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The plant hormone cytokinin regulates many aspects of growth and development. Cytokinin signaling involves His kinase
receptors that perceive cytokinin and transmit the signal via a multistep phosphorelay similar to bacterial two-component
signaling systems. The final targets of this phosphorelay are a set of Arabidopsis thaliana Response Regulator (ARR) pro-
teins containing a receiver domain with a conserved Asp phosphorylation site. One class of these, the type-A ARRs, are
negative regulators of cytokinin signaling that are rapidly transcriptionally upregulated in response to cytokinin. In this study,
we tested the role of phosphorylation in type-A ARR function. Our results indicate that phosphorylation of the receiver domain
is required for type-A ARR function and suggest that negative regulation of cytokinin signaling by the type-A ARRs most likely
involves phosphorylation-dependent interactions. Furthermore, we show that a subset of the type-A ARR proteins are
stabilized in response to cytokinin in part via phosphorylation. These studies shed light on the mechanism by which type-A
ARRs act to negatively regulate cytokinin signaling and reveal a novel mechanism by which cytokinin controls type-A ARR
function.
INTRODUCTION
Two-component signaling systems are used by prokaryotic and
eukaryotic organisms to sense and respond to changes in the
environment (Stock et al., 2000; West and Stock, 2001). In a
canonical two-component system, a stimulus is perceived by a
sensor kinase, which autophosphorylates on a conserved His
residue in the kinase domain. The signal is transmitted by transfer
of the phosphoryl group to a conserved Asp residue on the
receiver domain of a response regulator. Variations of the simple
two-component system involve intermediate elements in the
phosphotransfer from the sensor kinase to the response regu-
lator. Receiver domain phosphorylation induces conformational
changes, which, in most response regulators, release repression
of the output domain to allow the activation of downstream
processes, often transcriptional regulation. In some response
regulators, these conformational changes allow specific inter-
actions with target proteins.
The cytokinin signaling pathway is the best-characterized
system employing two-component elements in plants (Kakimoto,
2003; Ferreira and Kieber, 2005; Maxwell and Kieber, 2005;
Muller and Sheen, 2007). Cytokinins were discovered by their
ability to promote division in cultured cells (Miller et al., 1955) and
have since been implicated in almost every aspect of plant
growth and development and in the responses to various biotic
and abiotic environmental cues (Mok and Mok, 2001; Sakakibara,
2006).
In Arabidopsis thaliana, the three cytokinin receptors (Arabi-
dopsis Histidine Kinase2 [AHK2], AHK3, and AHK4) are hybrid
His kinases that contain a fused receiver domain in addition to an
input (a cytokinin binding CHASE domain) and a His kinase
domain (Inoue et al., 2001; Suzuki et al., 2001; Ueguchi et al.,
2001a, 2001b; Yamada et al., 2001). In response to cytokinin
binding, these receptors autophosphorylate on a conserved
His residue and relay this phosphoryl group to Arabidopsis
Response Regulators (ARRs) via an intermediate set of histidine
phosphotransfer (Hpt) proteins called the Arabidopsis Hpt pro-
teins (AHPs) (Suzuki et al., 1998; Hutchison et al., 2006). Similar
cytokinin signaling components have been characterized in
other plant species (Asakura et al., 2003; Ito and Kurata, 2006;
Jain et al., 2006; Pareek et al., 2006; Du et al., 2007).
The Arabidopsis response regulators fall into four classes
based on phylogenetic analysis and domain structure: type-A
ARRs, type-B ARRs, type-C ARRs, and the Arabidopsis pseudo-
response regulators (APRRs) (Schaller et al., 2007). The 10
type-A ARRs are primary transcriptional targets of cytokinin
signaling and contain short C-terminal extensions beyond the
conserved receiver domain (Brandstatter and Kieber, 1998;
Imamura et al., 1998; D’Agostino et al., 2000). The 11 type-B
ARRs contain C-terminal output domains that have DNA binding
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and transactivating activity (Sakai et al., 1998, 2000). Type-B
ARRs are positive regulators of cytokinin signaling that control
the transcription of a subset of cytokinin-regulated targets,
including the type-A ARRs (Hwang and Sheen, 2001; Sakai
et al., 2001; Tajima et al., 2004; Mason et al., 2005; Taniguchi
et al., 2007; Yokoyama et al., 2007). The type-C ARRs are more
distantly related to type-A and type-B ARR receiver domain
sequences. They do not contain the output domain of type-B
ARRs and are not transcriptionally regulated by cytokinin, al-
though their overexpression results in reduced sensitivity to
cytokinin (Kiba et al., 2004). The ARRs all contain the conserved
Asp required for receiver domain phosphorylation in bacterial
response regulators, and phosphotransfer from an AHP to rep-
resentative members of all three ARR groups has been demon-
strated in vitro (Suzuki et al., 1998; Imamura et al., 2001, 2003;
Kiba et al., 2004; Mahonen et al., 2006a). The APRRs lack the
conserved Asp phosphorylation site, and some play a role in
modulating circadian rhythms (McClung, 2006).
At least 8 of the 10 type-A ARRs act as partially redundant
negative regulators of cytokinin signaling (Kiba et al., 2003; To
et al., 2004; Lee et al., 2007b). ARR4 interacts directly with the
red light receptor phytochrome B and, along with other type-A
ARRs, modulates the response to red light (Sweere et al., 2001;
To et al., 2004). A subset of type-A ARRs are direct targets of the
transcription factor WUSCHEL and regulate shoot apical meri-
stem function (Leibfried et al., 2005). ARR3 and ARR4 are
involved in controlling the circadian clock, and this function is
opposed by ARR8 and ARR9 (Salomé et al., 2005). While it is
clear that type-A ARRs play a role in multiple signaling pathways,
little is known with regard to their mechanism of action.
There are two general models by which type-A ARRs can act to
negatively regulate cytokinin signaling (Figure 1A). In the first, the
type-A ARRs may compete with positively acting type-B ARRs
for phosphoryl transfer from the upstream AHPs, similar to the
chemotaxis system in Sinorhizobium meliloti (Schmitt, 2002). A
second model is that type-A ARRs regulate the pathway through
direct or indirect interactions with pathway components, as
observed in Escherichia coli chemotaxis (Bourret and Stock,
2002). These two models are not mutually exclusive.
Here, we explore the mechanism by which the type-A ARRs
negatively regulate cytokinin signaling and the role of phosphor-
ylation in this process. We show that type-A ARR function
requires phosphorylation and that the type-A ARRs likely interact
with other components in a phosphorylation-dependent manner
to generate negative feedback on the signaling pathway. In
addition, we show that a subset of the type-A ARR proteins are
stabilized by cytokinin, revealing a novel level of control of these
components.
RESULTS
To investigate the role of phosphorylation in type-A ARR func-
tion, we generated site-directed mutations in ARR5 that alter the
conserved phosphorylation site in the receiver domain (Figure
1B). The analogous conserved Asp in ARR7 (Asp-85), a closely
related type-A ARR, has been shown to be required for receiver
domain phosphorylation (Lee et al., 2007a). We mutated the con-
served phosphoryl-accepting Asp-87 in ARR5 to Ala (ARR5D87A)
to test whether phosphorylation of the type-A ARRs is necessary
for their function. An analogous D/A mutation in the bacterial
response regulator CheY has been shown to disrupt gene
function with negligible changes in protein structure compared
with the unphosphorylated wild-type CheY protein (Bourret et al.,
1993; Alon et al., 1998; Sola et al., 2000). The conserved Asp-87
residue in ARR5 was also mutated to Glu (ARR5D87E). Analogous
D/E changes in some bacterial and yeast response regulators
can partially mimic the phosphorylated and active protein form
(Klose et al., 1993; Moore et al., 1993; Brown et al., 1994; Gupte
et al., 1997; Lan and Igo, 1998). Previously, we had further shown
that a similar D/E change in ARR7, another type-A ARR, acts as
a gain-of-function mutation (Leibfried et al., 2005). Likewise, a
similar D/E change in the receiver domain of a type-B ARR
(ARR1) resulted in an activated form of this transcription factor,
presumably mimicking phosphorylation (Sakai et al., 2001). All
wild-type and mutant ARR5 proteins could interact with AHP2 in
a yeast two-hybrid assay (see Supplemental Figure 1 online),
indicating that the Asp-87 mutations do not strongly disrupt
ARR5 protein folding and that the interaction between ARR5 and
AHP2 is not dependent on ARR5 Asp-87 phosphorylation.
ARR5 Function Requires Receiver Domain Phosphorylation
To test whether ARR5WT, ARR5D87A, and ARR5D87E are func-
tional in planta, an arr3,4,5,6 mutant, which is hypersensitive to
cytokinin, was transformed with genomic constructs expressing
myc-tagged wild-type and mutant ARR5 from the endogenous
ARR5 promoter (Figure 1). We identified multiple independent
transgenic lines, and four lines that represented a range of
expression levels of the different transgenes (Figure 1D) were
tested for cytokinin sensitivity by a seedling root elongation
assay, as described previously (To et al., 2004).
Reintroduction of a wild-type genomic ARR5 gene was suffi-
cient to restore wild-type–like cytokinin sensitivity to the
arr3,4,5,6 mutant (Figures 1C and 1E). If the ARR5 transgene
were expressed identically to the endogenous ARR5 gene, then
the ARR5WT transgenic lines should closely resemble the arr3,4,6
mutant. However, in the four lines examined, cytokinin resistance
was restored beyond that of arr3,4,6 to nearly wild-type levels
and further increased resistance to higher levels of cytokinin
(Figures 1C, 1E, and 1F). One explanation for this is that the roles
of ARR3, ARR4, ARR5, and ARR6 are interchangeable in this
cytokinin assay and that the transgenic copy of ARR5 in these
lines is overexpressed. To test this, we isolated RNA from whole
seedlings and seedling roots grown under assay conditions and
analyzed the level of ARR5 transcripts by real-time PCR. In wild-
type seedlings, no significant increase in the steady state level of
ARR5 transcript was observed in response to the low levels of
cytokinin used in this assay (Figure 1G). In three of the four
arr3,4,5,6þ genomicARR5WT lines, the steady state level of
ARR5 transcripts was significantly higher than in the wild type
on 10 nM benzyladenine (BA) in both whole seedlings and
seedling roots (Figure 1G; data not shown). Consistent with the
model that cytokinin resistance correlates with the level of ARR5,
all four transgenic lines showed increased resistance to cytokinin
at 25 to 100 nM BA comparable to an ARR5-overexpressing line
(Figures 1F and 2), which correlates with higher ARR5 expression
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Figure 1. ARR5 Function Is Dependent on the Phosphorylation of Its Receiver Domain.
(A) Model of type-A ARR function in cytokinin signaling. Cytokinin is perceived by AHKs, which autophosphorylate and transmit the signal via AHPs to
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at 100 nM BA than in the wild type (Figure 1G). The two lines
displaying the highest level of ARR5 (lines 2 and 4) also showed
the strongest cytokinin resistance at 25 to 100 nM BA (Figure 1F).
Overexpression of ARR5 in these lines is most likely due to
positional effects of the transgene and/or the insertion of multiple
tandem copies of ARR5. Surprisingly, one line (line 1) displayed
close to wild-type levels of ARR5, despite displaying nearly wild-
type cytokinin sensitivity in root assays. One explanation could
be that this line may overexpress ARR5 in a specific subset of
root cells, which may not be detected in our analysis of RNA from
whole seedlings or full-length roots. An alternative explanation is
that the addition of the myc epitope tag may increase the
translatability of the transgenic ARR5 transcript, or may increase
the stability of the protein relative to endogenous ARR5, thus
allowing higher levels of protein accumulation.
If phosphorylation is required for ARR5 function, then intro-
ducing an ARR5D87A genomic fragment should not rescue the
cytokinin-hypersensitive phenotype of arr3,4,5,6. We analyzed
four independent transgenic lines that expressed ARR5D87A
protein at levels comparable to the four arr3,4,5,6þ genomi-
cARR5WT lines (Figure 1D). In all four lines, introduction of the
ARR5D87A transgene into arr3,4,5,6 did not decrease the sensi-
tivity to cytokinin, and in three lines, ARR5D87A expression further
increased cytokinin sensitivity compared with the parental line
(Figures 1C and 1E). Thus, phosphorylation of the receiver
domain is required for ARR5 function. The increased sensitivity
in some transgenic lines may be explained by ARR5D87A acting in
a dominant negative manner.
ARR5D87E Phosphomimic Is Partially Active
In bacterial systems, altering the Asp phosphorylation target to a
Glu can sometimes mimic the phosphorylated form, resulting in a
partially activated response regulator (Klose et al., 1993; Moore
et al., 1993; Brown et al., 1994; Gupte et al., 1997; Lan and Igo,
1998). This change can also block phosphorylation of the acti-
vated response regulator, thus preventing further activation
(Klose et al., 1993; Moore et al., 1993). If type-A ARRs negatively
regulate cytokinin signaling by acting as phosphate sinks and
thus reducing the flow of phosphates to the type-B ARRs, then
ARR5D87E should be completely nonfunctional. By contrast, if
type-A ARRs act by interacting with other proteins in a phos-
phorylation-dependent manner, then a phosphomimic mutant
may partially complement the arr5 loss-of-function mutation in
the arr3,4,5,6 parental line. To test this, we introduced a genomic
ARR5D87E transgene into arr3,4,5,6. Four independent trans-
genic lines showed transgenic protein expression comparable to
that of arr3,4,5,6þ genomicARR5WT and arr3,4,5,6þ genomi-
cARR5D87A (Figure 1D). In three of the four lines examined,
ARR5D87E partially restored cytokinin resistance significantly
above that of the arr3,4,5,6 parental line (Figures 1C and 1E).
Importantly, in three arr3,4,5,6þ genomicARR5D87E lines, cyto-
kinin responsiveness was restored significantly above that of
the arr3,4,5,6þ genomicARR5D87A lines (Student’s t test, P <
0.05 at 5 nM BA), indicating that the activation of the ARR5D87E
protein is specific to phosphomimickry and is not due to non-
specific phosphorylation at other sites in the absence of the
conserved Asp. The results indicate that mimicking the phos-
phorylated protein form is at least partially sufficient for ARR5
function. The effect of ARR5D87E is weaker than that of ARR5WT,
which is consistent with a partial activation of the mutant receiver
domain and the inability of ARR5D87E to be fully activated by
phosphorylation (Figure 1E) (Moore et al., 1993). This partial
complementation by ARR5D87E, which is unlikely to receive a
phosphoryl group from the AHPs, indicates that ARR5 does not
function entirely as a phosphate sink. Furthermore, it suggests
that the conformational state of phosphorylated ARR5 is likely to
be the active state for interactions with target proteins.
Figure 1. (continued).
ARRs in a His (H)-to-Asp (D) multistep phosphorelay. Type-A ARRs may compete for phosphotransfer with type-B ARRs or interact with targets to
negatively regulate the pathway.
(B) Type-A ARR protein is shown with conserved Asp (D) and Lys (K) residues characteristic of receiver domains. The conserved phosphorylation target
Asp (D) in the receiver domain is mutated to Ala (A) or Glu (E).
(C) to (G) Complementation of arr3,4,5,6 hypersensitivity to cytokinin inhibition of root elongation. Homozygous T3 seedlings were grown on vertical
Murashige and Skoog (MS) plates supplemented with the specified concentrations of BA or 0.1% DMSO control under constant light for 9 d.
(C) Two representative seedlings grown on 5 nM BA per genotype are pictured. Note: line 3 of arr3,4,5,6þ genomicARR5WT, line 4 of arr3,4,5,6þ
genomicARR5D87A, and line 1 of arr3,4,5,6þ genomicARR5D87E in (D) are shown.
(D) Transgenic seedlings express cytokinin-inducible myc-tagged wild-type and mutant ARR5 proteins. Full-length roots were harvested from 9-d-old
light-grown seedlings and were treated with 1 mM BA or 0.1% DMSO control for 2 h. Total proteins were extracted from root tissues and separated by
SDS-PAGE. ARR5-myc proteins were detected by protein gel blotting with anti-c-myc antibody. Note that a protein band of ;35 to 40 kD that binds
nonspecifically to anti-c-myc can be detected in all lanes, including untransformed arr3,4,5,6. The arrowhead indicates the position of a 32.5-kD protein
marker.
(E) Root elongation of seedlings from four independent transgenic lines was quantified between days 4 and 9 at the indicated cytokinin concentrations.
Error bars represent SE (n > 30). Asterisks indicate statistically significant differences from arr3,4,5,6 (indicated in red) at the given concentrations of BA
(Student’s t test, P < 0.05).
(F) Root elongation of seedlings were analyzed as in (E). Error bars represent SE (n > 30). Asterisks indicate statistically significant differences from the
wild type (indicated in red) at the given concentrations of BA (Student’s t test, P < 0.05). ARR5OX is as described for Figure 2.
(G) arr3,4,5,6þ genomicARR5WT expresses ARR5 transcript. RNA was extracted from seedlings grown under the same conditions as in (C) to (F) and
used for real-time RT-PCR analysis. ARR5 relative expression was normalized to b-tubulin levels and to the wild-type DMSO control using REST 2005
version 1.9.12. Error bars represent the upper and lower limits of 95% confidence intervals.
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Overexpression of Type-A ARRs Confers
Cytokinin Resistance
To test whether increasing the levels of other type-A ARRs can
confer cytokinin resistance, we expressed ARR4, ARR5, ARR6,
ARR7, and ARR9 in wild-type Arabidopsis as myc-epitope–
tagged fusion proteins from the constitutive cauliflower mosaic
virus (CaMV) 35S promoter. One representative line that ex-
pressed a detectable level of myc-ARR fusion protein was
selected and analyzed for cytokinin responsiveness (Figures 2A
and 2B). All transgenic lines tested were significantly more
resistant to 25 nM BA than the wild type in root elongation
assays (Figure 2C) (Student’s t test, P < 0.05) but less resistant
than the loss-of-function cytokinin receptor mutant ahk4.
A Subset of Type-A ARR Proteins Are Stabilized by Cytokinin
The regulation of protein turnover plays an important role in
controlling several phytohormone signaling and biosynthetic
pathways (reviewed in Dreher and Callis, 2007). We analyzed
ARR5 protein turnover using a dexamethasome (DEX)-inducible
myc-tagged ARR5 line (DMA5). Continuous growth of DMA5
seedlings on 10 nM DEX results in reduced sensitivity to cyto-
kinin, indicating that the ARR5 myc fusion protein in DMA5 is
functional (see Supplemental Figure 2 online).
The myc-ARR5 protein is rapidly degraded following the
inhibition of de novo protein synthesis by cycloheximide (CHX).
To test whether ARR5 protein turnover is regulated by cytokinin,
we compared ARR5 protein steady state levels and degradation
rates in the presence and absence of cytokinin. ARR5 protein
accumulated to higher steady state levels in the presence of
cytokinin, and this is the result of a decreased rate of protein
degradation (Figure 3A). Stabilization of ARR5 was effective
within 30 min of cytokinin application and was sensitive to
concentrations of BA as low as 10 nM (Figures 3A and 3B).
Cytokinin increased ARR5 protein stability when added simulta-
neously with the CHX treatment, indicating that the stabilization
of ARR5 protein by cytokinin does not require de novo protein
synthesis (Figure 3C).
To test whether other type-A ARR proteins are stabilized by
cytokinin, we analyzed the turnover of their respective myc fusion
proteins expressed from the CaMV 35S promoter. The five type-
A ARR proteins that we examined exhibited different rates of
protein turnover (Figures 3D and 3E). The half-lives of the myc-
ARR5 and myc-ARR6 fusion proteins were estimated to be 100
and 60 min, respectively. myc-ARR4, myc-ARR7, and myc-
ARR9 proteins exhibited longer protein half-lives, ;140, 160,
and 180 min, respectively. In the presence of exogenous cyto-
kinin, the myc-ARR5, myc-ARR6, and myc-ARR7 fusion proteins
were stabilized, with protein half-lives estimated to be >300 min.
The turnover of the myc-ARR4 and myc-ARR9 fusion proteins
was not significantly affected by cytokinin (Figures 3D and 3E).
Cytokinin-Mediated Stabilization of ARR5 Involves
Two-Component Phosphorelay
To test whether the stabilization of ARR5 by cytokinin is medi-
ated by the two-component signaling pathway, we expressed
myc-ARR5 in the background of two-component element mu-
tants. In the ahk3,4 and ahp1,2,3,4 mutants, cytokinin treatment
failed to stabilize myc-ARR5 (Figures 4A and 4B). These data
indicate that an intact AHK-AHP phosphorelay is required for
cytokinin to delay the turnover of type-A ARR proteins. Interest-
ingly, cytokinin-mediated stabilization of myc-ARR5 was also
reduced in a multiple type-B ARR loss-of-function mutant
(arr1,2,10,12) (Figure 4C). As de novo protein synthesis is not
required for the stabilization of ARR5 by cytokinin, this result
suggests that type-B ARRs are required for the transcription of
an element involved in the stabilization of ARR5 that is expressed
prior to cytokinin application in this assay. However, arr1,2,10,12
mutants still retain some response to cytokinin stabilization of
myc-ARR5, supporting the model that phosphorelay plays a role
in regulating myc-ARR5 turnover.
We tested the hypothesis that type-A ARR proteins are stabi-
lized by phosphorylation by analyzing the turnover of ARR
proteins mutated in the conserved Asp phosphorylation target.
We expressed ARR5D87A, ARR5D87E, ARR7D85A, and ARR7D85E
from the CaMV 35S promoter and compared their kinetics of
protein turnover with those of their respective wild-type proteins.
The myc-ARR5D87A protein was degraded more rapidly than
myc-ARR5WT in the absence of exogenous cytokinin; 15 min
after CHX treatment, myc-ARR5WT levels decreased 20%,
Figure 2. Wild-Type Type-A ARR Overexpression Confers Cytokinin
Resistance.
Overexpression of ARR4, ARR5, ARR6, ARR7, and ARR9 confers
cytokinin resistance.
(A) Seedlings were grown as described for Figure 1E with the specified
concentrations of BA or 0.1% DMSO control.
(B) Transgenic seedlings express myc-tagged ARR proteins, detected as
in Figure 1E. Bands corresponding to the relevant protein products
quantified in Figure 3 are noted with asterisks. Lower molecular mass
bands in ARR4 and ARR6 may represent degradation products. Arrows
indicate the positions of 47.5- and 32.5-kD protein markers.
(C) Root elongation was measured as described for Figure 1. Error bars
represent SE (n > 30). Asterisks indicate statistically significant differ-
ences from the wild type at the given concentrations of BA (Student’s t
test, P < 0.05).
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Figure 3. A Subset of Type-A ARR Proteins Are Stabilized by Exogenous Cytokinin Application.
(A) to (D) myc-ARR5 protein is stabilized by exogenous cytokinin. myc-ARR5 protein was generated in 7-d-old light-grown seedlings in a DEX-inducible
myc-ARR5 (DMA5) line by a 2-h 1 mM DEX treatment.
(A) Cytokinin stabilization of myc-ARR5 protein occurs within 30 min and is effective at 2 h. After DEX induction of myc-ARR5 protein production, 1 mM
BA or 0.1% DMSO control was added for the times indicated at left before CHX treatment.
(B) Cytokinin stabilization of ARR5 is sensitive to low concentrations of BA. Seedlings were treated with the indicated concentrations of BA or DMSO
control during DEX treatment, followed by CHX application.
(C) Cytokinin stabilization of myc-ARR5 does not require new protein synthesis. After DEX treatment, 200 mM CHX (or ethanol [EtOH] control) and 1 mM
BA (or 0.1% DMSO control) were applied simultaneously and myc-ARR5 protein turnover was analyzed as in (A).
(D) A subset of type-A ARRs are stabilized by exogenous cytokinin application. Seven-day-old light-grown ARR4OX, ARR5OX, ARR6OX, ARR7OX, and
ARR9OX seedlings were treated simultaneously with 200 mM CHX and 1 mM BA or 0.1% DMSO control. Three independent experiments were
conducted with consistent results, and one representative blot is shown.
(E) Relative myc-ARR protein levels were normalized to loading control and to myc-ARR protein levels at time 0. The results from three independent
experiments were averaged and shown with error bars indicating SE. Note that the upper band for ARR6 was quantified. An exponential best-fit curve
was fitted through the data points to estimate protein half-life. Correlation coefficient (R2) values are indicated as a measure of curve fit. Closed symbols
and solid lines represent DMSO control. Open symbols and broken lines represent BA treatment. The bottom right panel shows relative protein levels at
60 min after CHX treatment. Asterisks indicate statistical differences between BA treatment and DMSO control within each transgenic line (Student’s t
test, P < 0.05).
whereas myc-ARR5D87A levels decreased ;40%, compared
with the initial protein levels (Figures 5A to 5C). Cytokinin treat-
ment resulted in a strong stabilization of myc-ARR5WT protein,
but this was not observed with the myc-ARR5D87A protein
(Figures 5A to 5C). Consistent results were observed in wild-
type and mutant ARR5 proteins expressed from genomic con-
structs used for the complementation of arr3,4,5,6 (Figure 5D).
Similarly, in the absence of cytokinin, myc-ARR7D85A protein was
turned over more rapidly than myc-ARR7WT (Figures 5E to 5G),
and cytokinin treatment resulted in a stabilization of ARR7WT but
not ARR7D85A (Figures 5E to 5G). The rapid turnover of ARR5D87A
and ARR7D85A both in the presence and absence of cytokinin
suggests that the phosphorylation of Asp-85/87 plays a role in
regulating the turnover of these ARR proteins.
To further test the role of phosphorylation in type-A ARR
protein stability, we analyzed the protein turnover of myc-
ARR5D87E and myc-ARR7D85E phosphomimic mutants. When
expressed from the CaMV 35S promoter, basal myc-ARR5D87E
protein turnover was slower than that of myc-ARR5WT. At 60 min
after CHX addition, myc-ARR5WT proteins decreased by >40%,
whereas myc-ARR5D87E proteins only decreased by 10% (Fig-
ures 5A to 5C). In the presence of cytokinin, myc-ARR5D87E may
be weakly stabilized (Figures 5A to 5C), but the response is
greatly muted relative to that of myc-ARR5WT. Degradation of
the myc-ARR7D85E protein was also reduced in the absence of
cytokinin and was not altered significantly by cytokinin applica-
tion (Figures 5E to 5G). The delayed protein turnover of myc-
ARR5D87E and myc-ARR7D85E in the absence of cytokinin
suggests that the protein conformation induced by phosphoryl-
ation of the conserved Asp contributes to protein stability.
DISCUSSION
Type-A ARRs Are Likely to Negatively Regulate Cytokinin
Signaling by Phospho-Dependent Interactions
We investigated the mechanism by which type-A ARRs regulate
cytokinin signaling. Two distinct, but not mutually exclusive,
models for this mechanism are proposed: one invokes phos-
phocompetition between the type-A and type-B ARRs, and the
other involves phospho-dependent interactions of the type-A
ARRs with target proteins (Figure 1A). To test these models, we
generated two site-directed mutants targeting the Asp-87 res-
idue of ARR5, ARR5D87A, and ARR5D87E. This Asp residue is
conserved among response regulator family proteins and has
been shown to be the target of bacterial two-component
phosphorelay (Bourret et al., 1990; Stock et al., 2000; West
and Stock, 2001). Substitutions at this conserved Asp have also
been shown to abolish receiver domain phosphorylation in other
ARRs (Kim et al., 2006; Lee et al., 2007a). In bacterial response
regulators, this invariant Asp resides in the conserved active site
of the receiver domain that actively catalyzes phosphotransfer
from histidine kinases, Hpts, and small molecular phosphodo-
nors (Lukat et al., 1992; Stock et al., 2000; West and Stock,
2001). Analogous D/A and D/E substitutions in bacterial
response regulators have been shown to eliminate receiver
domain phosphorylation (Bourret et al., 1990, 1993; Drake
et al., 1993; Klose et al., 1993; Moore et al., 1993). The D/A
change has been shown to disrupt protein function (Bourret
et al., 1993; Klose et al., 1993; Moore et al., 1993; Alon et al.,
1998), and this defect is not due to perturbations in protein
structure (Sola et al., 2000). In some bacterial response regula-
tors, the D/E change has been shown to result in constitutive
but partial activation that is independent of two-component
phosphorelay (Klose et al., 1993; Moore et al., 1993; Gupte et al.,
1997; Lan and Igo, 1998). Response regulator activation by the
D/E mutation has also been demonstrated for Skn7 in yeast
and a type-B ARR (Brown et al., 1994; Sakai et al., 2001).
The ARR5 D87A substitution did not disrupt protein interac-
tions with AHP2 in our yeast two-hybrid analysis, indicating that
the D/A change does not significantly alter ARR5 protein
folding. When we expressed ARR5D87A under the control of the
native ARR5 promoter in a multiple loss-of-function type-A arr
mutant background, ARR5D87A failed to complement the cyto-
kinin hypersensitivity defect of the arr mutant. In addition, the
ARR5D87A protein further increased the cytokinin sensitivity of the
arr3,4,5,6 mutant. One explanation for the dominant negative
effect of ARR5D87A is that the protein is unable to be activated by
phosphorylation but retains its ability to interact with the AHPs,
thus reducing the activation of other type-A ARRs. In addition,
Figure 4. Cytokinin Stabilization of ARR5 Requires Upstream Cytokinin
Signaling Genes.
Protein turnover of DEX-inducible myc-ARR5 was examined in the
background of the cytokinin signaling mutants indicated. Seedlings
were treated and analyzed as described for Figure 3B. Relative protein
levels were normalized to tubulin and to myc-ARR5 levels at 0 min after
CHX treatment.
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Figure 5. ARR5 and ARR7 Protein Stability Is Dependent on the Conserved Phosphorylation Target Asp.
Seedlings expressing the proteins indicated were grown, treated, and analyzed as described for Figures 3D and 3E. In (C) and (G), asterisks indicate
significant differences in relative protein levels from ARR5WT or ARR7WT after the same treatment (Student’s t test, P < 0.05). The data for triplicate
analysis of ARR7WT protein degradation is presented in Figure 3E. In (D), genomic versions of myc-ARR5 were first induced by cytokinin to elevate myc-
ARR5 protein levels before treatment with CHX.
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cytokinin-inducible stabilization of the ARR5 protein, which is
dependent on two-component phosphorelay, is abolished in the
ARR5D87A protein. Together, these results indicate that the ARR5
D87A substitution eliminates phosphoryl Asp-57–dependent
activation, which is required for type-A ARR function.
The ARR5D87E protein also retained its ability to interact with
AHPs in yeast, indicating that the protein folding is relatively
conserved. Expression of ARR5D87E in a multiple type-A arr
mutant resulted in the partial rescue of cytokinin hypersensitivity,
which is the opposite effect compared with ARR5D87A. In addi-
tion, basal protein stability of the ARR5D87E protein was elevated
in both the absence and presence of exogenous cytokinin,
consistent with the ARR5D87E protein being a phosphomimic.
Together, these results indicate that the ARR5 D87E substitution
renders a partially activated type-A ARR, which is functional in
negatively regulating cytokinin signaling despite its inability to be
phosphorylated on Asp-57.
Our results from both the ARR5D87A and ARR5D87E mutants
have demonstrated that type-A ARRs require phosphorylation on
the conserved Asp for function in vivo and that a nonphosphor-
ylatable, partially activated form of the type-A ARR protein can
partially rescue a loss-of-function mutant. Together, our data
provide evidence that the phosphorylated type-A ARR protein
can negatively regulate cytokinin response independently of its
ability to compete for phosphoryl groups with the type-B ARRs
and suggest that this negative regulation may be mediated
through phosphospecific interactions with target proteins.
It is interesting that the expression of ARR5 wild type,
ARR5D87A, and ARR5D87E produced distinct effects on cytokinin
sensitivity in planta and that the three proteins also displayed
different levels of basal protein stability. In fact, the population of
the unphosphorylated bacterial response regulator NtrC has
been reported to consist of a mix of both active and inactive
receiver domain conformations, and the population is shifted to
predominantly active forms upon phosphorylation (Volkman
et al., 2001). This finding is consistent with the residual activity
found in the unphosphorylated bacterial response regulator
CheY (Barak and Eisenbach, 1992). Our data suggest that the
ARR5 D/A and D/E mutations shift the ARR5 protein popu-
lation toward the inactive and active receiver domain conforma-
tions, respectively, which may exhibit distinct properties.
Although our results suggest that type-A ARRs function in
cytokinin signaling through phospho-dependent interactions,
they do not rule out a role for type-A ARRs in phosphocompe-
tition. A recent study indicates that the cytokinin receptor AHK4
determines phosphate flux through the system by regulating a
bidirectional phosphorelay to and from the AHPs (Mahonen et al.,
2006b). A bidirectional phosphorelay is also used by the bacterial
Arc two-component system to mediate signal decay: the phos-
phoryl group from the ArcB response regulator is transferred
back to the receiver domain of the ArcA tripartite His kinase via its
His transmitter domain (Georgellis et al., 1998; Pena-Sandoval
et al., 2005). It is possible that type-A ARR function may act by a
similar mechanism of reverse phosphotransfer from type-B
ARRs to type-A ARRs via AHPs, because phosphotransfer
from AHPs to both type-A and type-B ARRs has been demon-
strated in vitro (Suzuki et al., 1998; Imamura et al., 2001, 2003)
and, in the presence of cytokinins, type-A ARRs, type-B ARRs,
and AHPs mostly localize to the same subcellular compartments
(Hwang and Sheen, 2001; Imamura et al., 2001, 2003; Kiba et al.,
2003). One argument against ARR5D87E acting as a phosphomi-
mic is that the protein may be nonspecifically and less efficiently
phosphorylated at an alternative site in the absence of the
conserved Asp. However, the catalytic nature of the conserved
active site surrounding the Asp phosphorylation target suggests
that nonspecific phosphorylation on the receiver domain is
unlikely (Stock et al., 2000; West and Stock, 2001). More impor-
tantly, the lack of activation of the ARR5D87A control indicates
that the activation of ARR5D87E must be a property specific to the
D87E substitution.
A previous study examined shoot formation from cultured
Arabidopsis roots overexpressing ARR4 and ARR8 and reported
that overexpression of ARR4 resulted in cytokinin hypersensitiv-
ity, whereas overexpression of ARR8 resulted in cytokinin insen-
sitivity (Osakabe et al., 2002). While we have not examined the
effect of ARR8 overexpression, our analysis of ARR4 (as well as
ARR5, ARR6, ARR7, and ARR9) overexpression in this study,
combined with other overexpression reports (Hwang and Sheen,
2001; Kiba et al., 2003; Lee et al., 2007b), as well as loss-of-
function mutants from our previous work (To et al., 2004), are
consistent with ARR4, as well as the other type-A ARRs, acting
as negative regulators of cytokinin signaling. One explanation for
this discrepancy is that ARR4 may act as a positive element in a
subset of cytokinin responses, such as shoot initiation. Indeed,
we have found antagonistic interactions among type-A ARRs in
other physiological roles, such as in controlling rosette size,
petiole length, and circadian rhythms (To et al., 2004; Salomé
et al., 2005).
Previous overexpression studies have also produced conflict-
ing data on the role of phosphorylation on type-A RR function.
Cytokinin resistance conferred by overexpression of a rice (Oryza
sativa) type-A RR was disrupted by mutating the conserved
phosphorylation target to either an unphosphorylatable residue
or a phosphomimic (Hirose et al., 2007). Similar results have also
been reported for overexpression of ARR22, which is a type-C
ARR (Kiba et al., 2004). One explanation is that the cytokinin-
insensitive phenotype conferred by overexpression of wild-type
type-A and type-C RRs may reflect an inappropriate diversion of
phosphate flow from the Hpts to the abnormally high levels of
type-A and type-C RR proteins, which would decrease the
activation of the type-B RRs. Whether this proposed phospho-
competition is an artifact of overexpression or accurately reflects
the role of endogenous type-A RR proteins is an open question.
By contrast, disruption of the conserved phosphorylation site did
not significantly alter the ability of type-A ARRs to reduce or
enhance a cytokinin-responsive reporter when overexpressed in
protoplasts (Hwang and Sheen, 2001). These differences may
reflect differences between the assay systems in these over-
expression studies. Our study expressing ARR5 under its en-
dogenous promoter in a loss-of-function mutant background
clearly shows that phosphorylated type-A ARRs can negatively
regulate cytokinin response in vivo, independently of phospho-
competition with the type-B ARRs, and that this negative feed-
back regulation may be mediated via interactions between the
type-A ARR in its phosphorylated protein conformation and
target proteins.
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Cytokinin Regulates Type-A ARR Function in Part by
Protein Stabilization
Control of protein stability through the proteasome degradation
machinery is a common mechanism for the regulation of plant
hormone responses (reviewed in Dreher and Callis, 2007). In-
deed, mutants of RPN12 and COP9/CIN4/ FUS10, which are sub-
units of proteasome regulatory structures (reviewed in Dreher
and Callis, 2007), are cytokinin-insensitive (Vogel et al., 1998;
Smalle et al., 2002), suggesting that cytokinin signaling may also
be regulated by the proteasome. One possible explanation is that
these mutants have higher levels of type-A ARR protein due to
decreased degradation. However, ARR5 protein stability is not
altered in rpn12a-1 or cin4/cop9/fus10 (see Supplemental Figure
3 online), indicating that cytokinin insensitivity in these mutants is
probably due to a distinct mechanism.
In this study, we have shown that cytokinin regulates the
turnover of a subset of type-A ARR proteins and that this occurs
in the absence of de novo protein synthesis. Cytokinin-mediated
stabilization of ARR5 is disrupted in mutants of upstream
phosphorelay components, suggesting that phosphorylation of
type-A ARRs by two-component elements is required for protein
stabilization by cytokinin. In addition, the unphosphorylatable
ARR5D87A and ARR7D85A mutant proteins are less stable and
their stability is not altered by cytokinin treatment, whereas
the partial phosphomimics, ARR5D87E and ARR7D85E, exhibit
reduced protein turnover compared with the wild-type proteins,
consistent with the idea that type-A ARR protein turnover is
determined by the phosphorylation state of the receiver domain.
Furthermore, stabilization by cytokinin is compromised in the
arr1,2,10,12 mutant, which is disrupted in cytokinin-activated
transcription factors and thus should have no direct effect on
the phosphorylation state of the type-A ARRs. These results
suggest that the mechanism for the stabilization of ARR5/ARR7
is dependent on type-B ARR basal transcription, because
de novo protein synthesis is not required for type-A ARR stabi-
lization.
A model in which ARR5 and ARR7 turnover is regulated by the
phosphorylation status of their receiver domains is consistent
with the finding that the yeast response regulator, SSK1, is
degraded by the 26S proteasome pathway and the degradation
of SSK1 is inhibited by the upstream phosphotransfer protein
YPD1 (Sato et al., 2003). In our yeast two-hybrid analysis, the
steady state protein levels of ARR5D87E prey fusion proteins are
higher than those of ARR5 or ARR5D87A fusion proteins, suggest-
ing that the ARR5 protein may also be subject to phosphoryla-
tion-dependent proteasome degradation in yeast.
Why Are a Subset of Type-A ARRs Stabilized?
The finding that cytokinin stabilizes a subset of type-A ARRs,
apparent negative regulators of cytokinin signaling, appears
distinct from other known phytohormone signaling pathways
involving proteasome degradation machinery, such as auxin,
gibberellin, and ethylene, which generally function to activate or
stabilize positively acting transcription factors (reviewed in Moon
et al., 2004; Fleet and Sun, 2005; Dreher and Callis, 2007).
However, in this study, we have shown that expression of the
phosphomimic ARR5D87E can partially complement a multiple
type-A ARR loss-of-function mutant; furthermore, our previous
results showed that ARR7D85E overexpression can further induce
meristem arrest at a low frequency (Leibfried et al., 2005).
Together, these results indicate that these proteins can function
without direct phosphotransfer from the AHPs and suggest that
phosphorylated, activated, and stabilized type-A ARR proteins
may interact with other targets, possibly to regulate output
beyond the cytokinin signaling circuitry.
Type-A ARRs, as a group, have been shown to be transcrip-
tionally upregulated by cytokinin and to function as redundant
negative regulators of cytokinin signaling (Brandstatter and
Kieber, 1998; Imamura et al., 1998; D’Agostino et al., 2000;
Hwang and Sheen, 2001; Kiba et al., 2003; To et al., 2004; Lee
et al., 2007b). Phenotypic analyses of loss-of-function and gain-
of-function mutants have indicated that subsets of type-A ARRs
may play distinct physiological roles (Sweere et al., 2001; To
et al., 2004; Leibfried et al., 2005; Salomé et al., 2005; Lee et al.,
2007b). In this study, we have shown that individual type-A ARRs
differ in both their intrinsic protein stabilities and the effect of
cytokinin on their protein turnover, which may suggest a mech-
anistic basis for functional specificity among type-A ARRs.
Interestingly, the effect of cytokinin on type-A ARR protein
turnover appears to correlate with their phylogenetic and func-
tional relationships. The type-A ARR proteins that are stabilized
by cytokinin, ARR5, ARR6, and ARR7, fall into a subset of ARRs
that are more similar in receiver domain sequence and contain
shorter C-terminal sequences (D’Agostino et al., 2000). ARR5,
ARR6, and ARR7 transcription are also highly induced by cyto-
kinin (D’Agostino et al., 2000) and are regulated by WUSCHEL,
likely to mediate interaction between cytokinin signaling and
meristem activity (Leibfried et al., 2005). The type-A ARR proteins
that are not stabilized by cytokinin, ARR4 and ARR9, are less
similar to ARR5, ARR6, and ARR7 in receiver domain sequence
and contain longer C-terminal regions (D’Agostino et al., 2000). In
addition, ARR4 and ARR9 are also less transcriptionally upregu-
lated by cytokinin (D’Agostino et al., 2000) and play a cytokinin-
independent role in modulating the circadian clock (Salomé
et al., 2005). The C-terminal regions of type-A ARR proteins may
impart specificity in protein regulation. Cytokinin regulation of
protein turnover of a subset of type-A ARRs may reflect another
mechanism for modulating their function in specific processes,
such as meristem activity.
In summary, we have shown that cytokinin regulates type-A
ARR activity by two-component phosphorelay, in part through
the control of protein stability. Targets of phosphorylated and
activated type-A ARRs may modulate cytokinin signaling or other
functions and remain to be determined.
METHODS
Plasmid Constructs
A genomic ARR5 DNA fragment (from 1.6 kb upstream of ATG through the
entire length of cDNA excluding the stop codon) (D’Agostino et al., 2000)
was amplified by PCR from genomic DNA isolated from wild-type
Arabidopsis thaliana ecotype Columbia seedlings and inserted into the
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pENTR/D-TOPO vector (Invitrogen) to generate Gateway entry clone
pAR5g. Full-length cDNAs of ARR4, ARR5, ARR6, ARR7, ARR9, and
AHP2 were amplified by PCR and inserted into the pENTR-D Gateway
entry clone vector (Invitrogen) to generate Gateway entry clones pAR4cs,
pAR5cs, pAR6cs, pAR7cs, pAR9cs, and pAP2cs. In the coding region for
ARR5 in pAR5g and pAR5cs, the 87th codon GAT encoding Asp-87 of
ARR5 cDNA, was changed to GCT, encoding Ala, by site-directed
mutagenesis to generate pAR5gDA and pAR5DAcs, respectively. The
same codon for Asp-87 was changed to GAG, encoding Glu, to generate
pAR5DEs and pAR5gDE. In pAR7s, Asp-85 was changed to Ala and Glu
by site-directed mutagenesis to generate pAR7DAcs and pAR7DEcs,
respectively. All entry clones were sequence-verified.
For ARR5 complementation constructs, a genomic ARR5 fragment
was transferred from pAR5g, pAR5gDA, and pAR5gDE into Gateway-
compatible binary vector pGWB16 (a gift from Tsuyoshi Nakagawa,
Shimane University) to generate pB16-5gw, pB16-5gDA, and pB16-
5gDE, respectively. Each of the resulting constructs carried the endog-
enous ARR5 promoter driving the expression of wild-type or mutant
ARR5 with a 43 C-terminal myc tag.
For ARR overexpression constructs, full-length ARR cDNAs were
transferred from Gateway entry vectors pAR4cs, pAR5cs, pAR6cs,
pAR7cs, pAR9cs, pAR5DAcs, pAR5DEcs, pAR7DAcs, and pAR7DEcs
into the Gateway-compatible binary vector pGWB18 (a gift from Tsuyoshi
Nakagawa) by LR recombination (Invitrogen) to generate pB18-4w,
pB18-5w, pB18-6w, pB18-7w, pB18-9w, pB18-5DA, pB18-5DE, pB18-
7DA, and pB18-7DE, respectively. In each of the resulting constructs,
expression of an ARR cDNA carrying a 43 N-terminal myc tag was driven
by the constitutive CaMV 35S promoter.
To generate a DEX-inducible 63 N-terminal myc-tagged ARR5 con-
struct, a full-length ARR5 cDNA fragment was introduced into a 63 myc
vector via EcoRI sites and subcloned into pTA7002 (Aoyama and Chua,
1997) to generate pDMA5.
Plant Materials and Transgenic Lines
Arabidopsis plants of the Columbia ecotype were used in all experiments
as the wild-type control unless stated otherwise. Mutant lines arr3,4,5,6
(To et al., 2004), ahk3,4 (Rashotte et al., 2006), arr1,2,10,12 (Rashotte
et al., 2006), and ahp1,2,3,4 (Hutchison et al., 2006) have been described
previously.
All transgenic plant lines described here were generated in the Colum-
bia ecotype background by introducing binary plasmid constructs via
Agrobacterium tumefaciens–mediated floral dip (Clough and Bent, 1998).
pB16-5gw, pB16-5gDA, and pB16-5gDE were introduced into arr3,4,5,6
to generate arr3,4,5,6þ genomicARR5WT, arr3,4,5,6þ genomicARR5D87A,
and arr3,4,5,6þ genomicARR5D87E, respectively. At least eight indepen-
dent single-locus insertion lines were analyzed in the T2 generation and
taken to T3 homozygosity. Detailed characterization of homozygous T3
progeny from four independent lines is presented in this article.
pB18-4w, pB18-5w, pB18-6w, pB18-7w, pB18-9w, pB18-5DA, pB18-
5DE, pB18-7DA, pB18-7DE, and pDMA5 were introduced into wild-type
Columbia to generate ARR4OX, ARR5OX, ARR6OX, ARR7OX, ARR9OX,
ARR5D87AOX, ARR5D87EOX, ARR7D85EOX, ARR7D85EOX, and DMA5,
respectively. Transgenic T1 seedlings were selected on MS agar plates
(see below) supplemented with 30 mg/mL hygromycin and 50 mg/mL
carbenicillin. Transgene expression was confirmed in homozygous hy-
gromycin-resistant T3 seedlings by protein gel blotting of whole seedling
protein extracts and detection with anti-c-myc POD antibody (Roche
Applied Science). For each construct, the results from one representative
line are presented.
To generate DEX-inducible myc-ARR5 lines in the various genetic
backgrounds, ahk3,4 was crossed to DMA5. pDMA5 was introduced into
ahp1,2,3,4 and arr1,2,10,12 and selected as described above.
Plant Growth Conditions
Seeds were surface-sterilized and cold-treated at 48C for 3 d in the dark
and grown at 238C under constant white light (;100 mE). Seedlings were
grown on MS medium containing 13 MS salts, 0.05% MES buffer, and
1% sucrose, pH 5.7. For cytokinin response assays, seedlings were
grown on vertical MS plates with 0.6% phytagel (Sigma-Aldrich) supple-
mented with a dose range of N6-BA or 0.1% (v/v) DMSO carrier control as
described previously (To et al., 2004). For protein assays and transgenic
seedling selection, seedlings were grown on horizontal MS plates with
0.8% bactoagar.
Quantitative Real-Time RT-PCR
Ten-day-old light-grown seedlings in cytokinin response assays were
harvested, and total RNA was extracted from both whole seedlings and
full-length roots using an RNeasy kit according to the manufacturer’s
instructions (Qiagen). cDNA was generated from the RNA with Moloney
murine leukemia virus reverse transcriptase (Invitrogen). Quantitative
RT-PCR was performed with Taq DNA Polymerase Hot-Start Version,
buffer, and deoxynucleotide triphosphates according to the manufac-
turer’s instructions (Takara Mirus Bio) supplemented with 0.33 SYBR
Green (Molecular Probes) and ARR5 primers ARR5F3 (59-TCTGAAGAT-
TAATTTGATAATGACGG-39) and ARR5R2 (59-TCACAGGCTTCAATAAG-
AAATCTTCA-39) or b-tubulin primers TUB4s (59-AGAGGTTGACGAGCA-
AGATGA-39) and TUB4a (59-AACAATGAAAGTAGACGCCA-39). Real-time
PCR was performed in an Opticon2 PCR machine (MJ Research) using
the following thermocycler program: (1) 2 min at 958C; (2) 15 s at 958C;
(3) 15s at 608C; (4) 15 s at 728C; (5) optical read, repeat 34 cycles of steps
2 through 5, followed by a final analysis of product melting temperature
to confirm the PCR product. Each biological sample was analyzed at
least twice in triplicate. The relative expression for ARR5 (normalized
to b-tubulin as a reference gene and to the wild type grown on DMSO
as a control sample) and 95% confidence intervals were determined
using REST 2005 version 1.9.12 (Pfaffl et al., 2002; http://rest-2005.
gene-quantification.info). Two independent experiments were performed
with consistent results. The data from one triplicate analysis are presented.
Analysis of Protein Stability
For DEX-inducible myc-tagged ARR5, myc-ARR5 protein expression was
induced by incubating 7-d-old light-grown seedlings in liquid MS medium
with 1 mM DEX supplemented with 1 mM BA or 0.1% (v/v) DMSO carrier
control for 2 h. Protein synthesis was inhibited by 200 mM CHX. Seedlings
were harvested by flash freezing in liquid nitrogen at the time points
indicated.
For lines constitutively overexpressing ARRs, 7-d-old light-grown
seedlings were incubated in liquid MS medium with 200 mM CHX
supplemented with 1 mM BA or DMSO carrier control. Seedlings were
harvested at the time points indicated.
Protein extracts were prepared in 250 mM Tris, pH 8, 150 mM NaCl,
5 mM EDTA, 13 Complete protease inhibitors (Roche Applied Science),
and 0.5% b-mercaptoethanol. Protein extracts were separated by SDS-
PAGE and transferred to Nitropure membranes (GE). myc-tagged pro-
teins were detected with anti-c-myc POD (Roche Applied Science), and
tubulin was detected by rabbit polyclonal anti-tubulin and secondary goat
anti-rabbit POD antibodies (Chemicon) and visualized by chemilumines-
cent detection (Perkin-Elmer) by autoradiography. Films were quantified
using ImageQuant software (Molecular Dynamics). myc-ARR protein
levels were normalized to signal from b-tubulin or from nonspecific anti-
c-myc hybridization to a 35- to 40-kD protein. Three independent ARR
protein degradation time course experiments were conducted for each
line, and the results were averaged. Protein half-lives of myc-ARRs were
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estimated by plotting an exponential best-fit curve to the averaged data
from three independent experiments.
Accession Numbers
The Arabidopsis Genome Initiative locus identifiers for the genes char-
acterized in this study are as follows: ARR4 (At1g10470), ARR5
(At3g48100), ARR6 (At5g62960), ARR7 (At1g19050), and ARR9
(At3g57040).
Supplemental Data
The following materials are available in the online version of this article.
Supplemental Figure 1. Mutations Targeting the Conserved Phos-
phorylation Target Asp Do Not Disrupt ARR5 Protein Interaction with
AHP2 in the Yeast Two-Hybrid Assay.
Supplemental Figure 2. Exogenous DEX Application Enhances
Cytokinin Resistance in DMA5 Seedlings.
Supplemental Figure 3. Mutations in RPN12a and COP9/CIN4/
FUS10 Do Not Alter myc-ARR5 Protein Stability.
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